Policies and Practices Catalyzing the Use of Generic Medicines: A Systematic Search and Review.
Brandgeneric
Cost saving
Generic medicines
Policies and practices
Systematic review
Journal
Ethiopian journal of health sciences
ISSN: 2413-7170
Titre abrégé: Ethiop J Health Sci
Pays: Ethiopia
ID NLM: 101224773
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
entrez:
23
6
2021
pubmed:
24
6
2021
medline:
19
8
2021
Statut:
ppublish
Résumé
The use of generic medicines instead of branded, is one of the main policies to decrease the expenditures and provide access to affordable and essential medicines in low and middle-income countries. The present study aims to systematically create a comprehensive synthesis of demand-side policies, encouraging the use of generic medicines. The study systematically searched and reviewed the articles in Medline, Scopus, Web of Science, and Embase from 1.1.2000 to 12.5.2019. A total of 6435 records were identified during this period of time (Medline (n=315), Scopus (n=4323), Web of Science (n=71) and Embase (n=1726)). All stages are conducted according to the Preferred Reporting Item for Systematic Reviews and Meta-Analyzed (PRISMA). The encouraging policies and practices were classified into four categories from 44 articles analyzed, including; Prescribing, Dispensing, Patients/consumers, and healthcare organizations. Subthemes were also explored in relation to each category as; education, financial incentives, generic substitution, advertising approaches, and enforcement. Various policies should be taken into consideration to encourage successful generic medication prescribing, dispensing, and consumption in both supply and demand-side. Economic, political, socio-cultural, technological, legal, and structural factors could as such accelerate the policies' effect. Studying the experience of successful countries can be helpful for policymakers.
Sections du résumé
BACKGROUND
BACKGROUND
The use of generic medicines instead of branded, is one of the main policies to decrease the expenditures and provide access to affordable and essential medicines in low and middle-income countries. The present study aims to systematically create a comprehensive synthesis of demand-side policies, encouraging the use of generic medicines.
METHODS
METHODS
The study systematically searched and reviewed the articles in Medline, Scopus, Web of Science, and Embase from 1.1.2000 to 12.5.2019. A total of 6435 records were identified during this period of time (Medline (n=315), Scopus (n=4323), Web of Science (n=71) and Embase (n=1726)). All stages are conducted according to the Preferred Reporting Item for Systematic Reviews and Meta-Analyzed (PRISMA).
RESULTS
RESULTS
The encouraging policies and practices were classified into four categories from 44 articles analyzed, including; Prescribing, Dispensing, Patients/consumers, and healthcare organizations. Subthemes were also explored in relation to each category as; education, financial incentives, generic substitution, advertising approaches, and enforcement.
CONCLUSION
CONCLUSIONS
Various policies should be taken into consideration to encourage successful generic medication prescribing, dispensing, and consumption in both supply and demand-side. Economic, political, socio-cultural, technological, legal, and structural factors could as such accelerate the policies' effect. Studying the experience of successful countries can be helpful for policymakers.
Identifiants
pubmed: 34158764
doi: 10.4314/ejhs.v31i1.19
pii: jEJHS.v31.i1.pg167
pmc: PMC8188110
doi:
Substances chimiques
Drugs, Generic
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
167-178Informations de copyright
© 2021 Shahmoradi M., et al.
Références
Cochrane Database Syst Rev. 2008 Jan 23;(1):CD007017
pubmed: 18254125
Croat Med J. 2002 Aug;43(4):462-9
pubmed: 12187525
Expert Rev Pharmacoecon Outcomes Res. 2019 Apr 8;:1-8
pubmed: 30958724
Expert Rev Pharmacoecon Outcomes Res. 2014 Jun;14(3):345-53
pubmed: 24758569
Trop Med Int Health. 2016 Dec;21(12):1504-1512
pubmed: 27671539
PLoS One. 2013 Sep 30;8(9):e74399
pubmed: 24098644
Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):181-94
pubmed: 24450984
Expert Rev Pharmacoecon Outcomes Res. 2009 Dec;9(6):569-81
pubmed: 19941434
BMC Health Serv Res. 2014 Aug 15;14:343
pubmed: 25128190
PLoS Med. 2009 May 5;6(5):e1000074
pubmed: 19434227
Eur J Health Econ. 2005 Sep;6(3):267-73
pubmed: 15977036
Expert Rev Clin Pharmacol. 2008 Jul;1(4):497-503
pubmed: 24410552
Arch Intern Med. 2004 Feb 23;164(4):427-32
pubmed: 14980994
Aust Health Rev. 2014 Feb;38(1):6-15
pubmed: 24480618
J Gen Intern Med. 2008 Jun;23(6):709-14
pubmed: 18365289
Expert Rev Pharmacoecon Outcomes Res. 2013 Aug;13(4):469-82
pubmed: 23977975
Expert Rev Pharmacoecon Outcomes Res. 2015 Feb;15(1):33-42
pubmed: 25138241
Electron Physician. 2015 Nov 20;7(7):1470-5
pubmed: 26767100
Front Pharmacol. 2017 Dec 18;8:892
pubmed: 29326583
Saudi Pharm J. 2014 Dec;22(6):491-503
pubmed: 25561861
BMJ Open. 2014 May 14;4(5):e004623
pubmed: 24833683
Arch Intern Med. 2008 Dec 8;168(22):2433-9
pubmed: 19064827
Int J Health Plann Manage. 2005 Oct-Dec;20(4):291-306
pubmed: 16335079
Health Syst Transit. 2016 Oct;18(5):1-122
pubmed: 27929376
Health Policy. 2014 Sep;117(3):285-96
pubmed: 24973926
BMC Health Serv Res. 2011 Apr 27;11:89
pubmed: 21524312
Rev Panam Salud Publica. 2017 Apr 20;41:e5
pubmed: 28444005
Expert Rev Pharmacoecon Outcomes Res. 2013 Feb;13(1):59-72
pubmed: 23402447
Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):795-803
pubmed: 25095903
Health Econ. 2018 Aug;27(8):1264-1283
pubmed: 29786162
BMC Health Serv Res. 2006 Mar 14;6:33
pubmed: 16536865
BMC Health Serv Res. 2017 Jan 13;17(1):27
pubmed: 28086866
Pharmacoeconomics. 2005;23(8):755-66
pubmed: 16097838
PLoS Med. 2011 Apr;8(4):e1000431
pubmed: 21483716
BMJ Open. 2017 Sep 27;7(9):e016408
pubmed: 28963287
South Med Rev. 2010 Feb;3(1):11-8
pubmed: 23093878
Milbank Q. 2017 Sep;95(3):554-601
pubmed: 28895227
Health Policy. 2012 Aug;106(3):211-24
pubmed: 22694970
Health Serv Manage Res. 2019 Feb;32(1):49-56
pubmed: 29376411
J Med Econ. 2008;11(1):171-5
pubmed: 19450118
Indian J Pharm Sci. 2012 Nov;74(6):571-5
pubmed: 23798785
Adv Med Educ Pract. 2015 May 15;6:359-66
pubmed: 26028981
Health Policy. 2000 Apr;51(3):149-62
pubmed: 10720685
Res Social Adm Pharm. 2016 Sep-Oct;12(5):807-10
pubmed: 27157864
Iran J Pharm Res. 2017 Winter;16(1):1-7
pubmed: 28496457